Univest
Univest
  • Markets

RPG Life Sciences Hits 52-Week High of Rs 3,131: What’s Driving the Stock Today

  • September 25, 2026
  • Posted by: Harsh Piplani
  • Category: News
No Comments
RPG Life Sciences Share Price
RPG Life Sciences Ltd. (RPGLIFE) share price reached a fresh 52-week high of Rs 3,130.5 today and later stood at Rs 3,060.65, up 5.58% from the previous close. Market cap was Rs 5,017.19 crore.

Published: 25 September 2026 at 3:18 PM IST

RPG Life Sciences Share Price moved higher today, with RPGLIFE closing at Rs 3,060.65 after a 5.58% rise from the previous close of Rs 2,898.90. The stock also touched a fresh 52-week high of Rs 3,130.50 during the session, while market capitalisation stood at Rs 5,017.19 crore. The latest RPGLIFE Share Price action confirms a new yearly high, but the supplied data does not establish a company-specific catalyst. For readers tracking RPG Life Sciences Share Price Today, the event matters because it combines a fresh high with valuation, sector and peer context that can be checked against the company’s fundamentals and the broader healthcare space. Univest is covering the move as part of its RPGLIFE Stock News and market update flow.

The stock opened at Rs 2,899.00 and traded between Rs 2,868.35 and Rs 3,130.50 before settling above the previous close. Turnover stood at Rs 1.34 crore. In RPGLIFE Share Price terms, that makes the session notable for both the new 52-week peak and the size of the move versus the prior close. Univest readers following RPG Life Sciences Share Price Today can treat this as a verified price event first, then examine the company’s valuation and sector backdrop before drawing any broader conclusion.

Table of Contents

Toggle
  • RPG Life Sciences Share Price Today: Price Action Analysis
  • RPG Life Sciences Ltd. (RPGLIFE) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching RPGLIFE
  • About RPG Life Sciences
  • Track RPGLIFE Share Price on Univest
  • Frequently Asked Questions
    • Why did RPG Life Sciences share price hit a fresh 52-week high?
    • What was the RPGLIFE share price today?
    • What is the market capitalisation of RPG Life Sciences?
    • How does RPGLIFE look on valuation metrics?
    • What do the profitability ratios show for RPGLIFE?
    • What are the EPS and book value for RPG Life Sciences?

RPG Life Sciences Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 3,060.65
Previous Close Rs 2,898.9
Today's Move +Rs 161.75 (+5.58%)
Open Rs 2,899
High Rs 3,130.5
Low Rs 2,868.35
Turnover Rs 1.34 crore
Market Capitalisation Rs 5,017.19 crore

RPG Life Sciences Ltd. (RPGLIFE) traded at Rs 3,060.65 versus the previous close of Rs 2,898.9, a rise of 5.58%. The stock opened at Rs 2,899, reached a high of Rs 3,130.5 and touched a low of Rs 2,868.35.

RPG Life Sciences Share Price Today showed a clear upward session in which the stock added Rs 161.75, or 5.58%, against the previous close of Rs 2,898.90. The day’s open was almost unchanged at Rs 2,899.00, and the stock advanced to Rs 3,130.50, which matched the fresh 52-week high. The intraday low was Rs 2,868.35, while turnover came in at Rs 1.34 crore. This combination confirms a one-year high event for RPGLIFE Share Price and gives a precise view of the day’s price range without adding an unverified trigger. For readers scanning RPG Life Sciences Stock News, the important fact is the fresh high itself and the exact path taken by the share price during the session.

In market terms, RPGLIFE Share Price news is relevant because the session closed near the upper end of the day’s range and above the previous close. That is the factual pattern visible in the data. Univest is presenting the move as RPGLIFE Share Price Live coverage rather than a narrative about cause or intent. The next step is to look at financial metrics, because a 52-week high becomes more useful when set against valuation and profitability data.

RPG Life Sciences Ltd. (RPGLIFE) Fundamental Analysis

Metric Value
Market Capitalisation Rs 5,017.19 crore
P/E Ratio 41.63x
P/B Ratio 7.54x
ROE 20.28%
ROCE 26.99%
EPS Rs 69.64
Book Value Per Share Rs 384.61
Dividend Yield 0.83%

RPG Life Sciences Ltd. (RPGLIFE) fundamental metrics show P/E 41.63x, P/B 7.54x, ROE 20.28%, ROCE 26.99%. These figures provide context only and are not a buy or sell signal.

RPG Life Sciences Ltd. has a market capitalisation of Rs 5017.19 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 41.63x, P/B at 7.54x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 20.28% and ROCE of 26.99%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 69.64, book value per share of Rs 384.61, dividend yield of 0.83%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.49x, median ROE of 11.7%, median ROCE of 13.46%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Pharmaceuticals & Drugs
Benchmark Scope same industry
Company P/E Ratio 41.63x
Benchmark Median P/E 32.49x
Benchmark Average P/E 49.63x
Benchmark P/E Range 3.48x to 757.76x
Company P/B Ratio 7.54x
Benchmark Median P/B 2.94x
Company ROE 20.28%
Benchmark Median ROE 11.7%
Company ROCE 26.99%
Benchmark Median ROCE 13.46%
Company Market Capitalisation Rs 5,017.19 crore
Benchmark Median Market Cap Rs 793.62 crore

RPG Life Sciences Ltd. (RPGLIFE) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

RPG Life Sciences Ltd. (RPGLIFE) has a P/E ratio of 41.63x, which is above the benchmark median of 32.49x, a difference of +28.13%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

RPG Life Sciences Ltd. (RPGLIFE) has a ROE of 20.28%, which is above the benchmark median of 11.7%, a difference of +73.33%. RPG Life Sciences Ltd. (RPGLIFE) has a ROCE of 26.99%, which is above the benchmark median of 13.46%, a difference of +100.52%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Gujarat Themis Biosyn Ltd. GUJTHEM 5,323.2 109.34 5.08 17.41 18.16
SMS Pharmaceuticals Ltd. SMSPHARMA 4,521.52 43.4 5.51 12.49 13.32
FDC Ltd. FDC 5,706.49 19.23 2.15 11.81 15.93
Gufic Biosciences Ltd. GUFICBIO 4,381.34 57.51 6.15 10.14 12.56
IOL Chemicals And Pharmaceuticals Ltd. IOLCP 6,064.28 35.58 3.21 7.9 10.65

RPG Life Sciences Ltd. (RPGLIFE) has a P/E ratio of 41.63x compared with the displayed peer median of 43.4x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 20.28% compares with a peer median of 11.81% across the companies shown in the table. ROCE stood at 26.99% versus the displayed peer median of 13.32%, providing a capital-efficiency comparison. RPG Life Sciences Ltd. (RPGLIFE) has a market capitalisation of Rs 5,017.19 crore. Among the 5 peers shown, 3 have a larger market capitalisation.

Why Investors Are Watching RPGLIFE

  • RPGLIFE Share Price closed at Rs 3,060.65 after a 5.58% rise from Rs 2,898.90.
  • The stock touched a fresh 52-week high of Rs 3,130.50 during the session.
  • Market capitalisation stood at Rs 5,017.19 crore on the latest RPGLIFE Share Price update.
  • P/E of 41.63, P/B of 7.54, ROE of 20.28% and ROCE of 26.99% are all explicit published metrics.
  • Same-industry benchmark data shows the company P/E, P/B, ROE and ROCE against 198 Pharmaceuticals & Drugs names.

About RPG Life Sciences

RPG Life Sciences Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied company profile and financial data identify it as a listed Indian business with NSE and BSE presence reflected in the RPGLIFE stock identity used on Univest. For readers checking RPGLIFE Share Price and RPGLIFE Company News, the available facts centre on the company’s market capitalisation, profitability ratios, earnings per share, book value and dividend yield. Univest is keeping this section strictly to verified company classification and company-level financial context.

Track RPGLIFE Share Price on Univest

Use RPG Life Sciences Ltd. (RPGLIFE) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Users can track RPGLIFE Share Price on Univest for live share price movement, shareholding pattern, 52-week levels, valuation ratios, financial results and market insights. The same page also helps readers review RPG Life Sciences Share Price Today alongside the broader RPGLIFE Stock News flow, sector comparison and company metrics in one place.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions

Why did RPG Life Sciences share price hit a fresh 52-week high?

Ans. RPGLIFE Share Price touched Rs 3,130.50, its fresh 52-week high, and closed at Rs 3,060.65. The supplied data confirms the price event, but it does not establish a company-specific catalyst for the move.

What was the RPGLIFE share price today?

Ans. RPGLIFE Share Price closed at Rs 3,060.65 today, up Rs 161.75 or 5.58% from the previous close of Rs 2,898.90. The session also produced a fresh 52-week peak of Rs 3,130.50.

What is the market capitalisation of RPG Life Sciences?

Ans. RPG Life Sciences has a market capitalisation of Rs 5,017.19 crore. That places RPGLIFE above the same-industry market cap median of Rs 793.62 crore in the supplied healthcare benchmark set.

How does RPGLIFE look on valuation metrics?

Ans. RPGLIFE trades at a P/E of 41.63 and P/B of 7.54. Both are above the same-industry medians of 32.49 and 2.94, so the valuation sits above the benchmark middle. The company trades at a P/E ratio of 41.63x.

What do the profitability ratios show for RPGLIFE?

Ans. RPG Life Sciences reports ROE of 20.28% and ROCE of 26.99%. Both exceed the same-industry medians of 11.70% and 13.46%, which gives the stock a stronger profitability profile than the benchmark median.

What are the EPS and book value for RPG Life Sciences?

Ans. EPS is 69.64 and book value is Rs 384.61. EPS shows earnings attributable to each share, while book value reflects accounting net worth per share; both are useful in RPGLIFE Share Price analysis.



Author: Harsh Piplani
I am Harsh Piplani, an Assistant Content Manager with over 5 years of experience in crafting impactful, result-driven content. I hold a B.Com (Hons) degree and have worked across diverse industries, including education, fintech, healthcare, jewellery, and more. I specialise in content strategy, SEO, and optimisation, ensuring that every piece I create is not just well-written but also well-ranked. I believe content should do more than fill space so as to drive traffic, build authority, and support business growth. I enjoy turning complex ideas into clear, engaging narratives, and, as I like to say, I know how to spin words like a web to influence, structured, strategic, and impossible to ignore. For me, great content sits at the intersection of creativity and performance.

Leave a Reply Cancel reply